))
Lung Cancer Edition: Top Headlines for Week of June 5, 2023
Manage episode 407442268 series 3560281
Content provided by Healio. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Healio or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this edition, surgery confers higher 5-year survival rates than radiotherapy; first-line combination extends PFS in lung cancer subgroup; pembrolizumab improves outcomes in early-stage resectable lung cancer, and more.
Read the full coverage here:
Surgery confers higher 5-year survival rates than radiotherapy in early-stage lung cancer
First-line combination extends PFS in lung cancer subgroup
Pembrolizumab improves outcomes in early-stage resectable lung cancer
Chemotherapy after first-line EGFR TKI fails to extend survival in advanced NSCLC
Severe myelosuppression common after chemotherapy for small cell lung cancer
References:
Hart L, et al. Cancer Med. 2023;doi:10.1002/cam4.5738.
Kanda S, et al. Abstract LBA9009. Presented at: ASCO Annual Meeting; June 2-6, 2023; Chicago.
Udelsman B, et al. Abstract 275. Presented at: American Association for Thoracic Surgery Annual Meeting; May 6-9, 2023; Los Angeles.
Wakelee H, et al. Abstract LBA100. Presented at: ASCO Annual Meeting; June 2-6, 2023; Chicago.
114 episodes
Share
